Braskem (BRKM5) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Recurring EBITDA reached US$192 million in 1Q26, up 76% from 4Q25, driven by higher spreads, operational normalization, and positive tax credits in Brazil, with improved performance in the US and Europe, despite a negative result in Mexico.
Net income attributable to shareholders was US$275 million, reversing a loss in the previous quarter, mainly due to positive exchange rate effects and tax asset write-offs.
Cash position ended at US$1.1 billion, with operating cash consumption of US$603 million (R$3.2 billion), mainly due to negative working capital changes, inventory replenishment, and interest payments.
Returned to ISE B3 Corporate Sustainability Index and became the first chemical company to receive Selo Verde Brasil for bio-based products.
Significant progress in capital structure reorganization and negotiations with creditors.
Financial highlights
Net revenue was US$2.95 billion, down 1% sequentially and 12% year-over-year.
Recurring EBITDA margin improved to 7% in 1Q26, up from 4% in 4Q25.
Adjusted net debt increased to US$8.5 billion, with corporate leverage at 16.81x.
Gross debt stood at US$12.05 billion, with an average debt maturity of 7.4 years and 91% in foreign currency.
Cash and cash equivalents decreased 46% sequentially to US$1.16 billion.
Outlook and guidance
Priorities for 2026 include capital structure reorganization, liquidity preservation, competitiveness initiatives, and sustainability expansion.
External consultancies expect material improvement in petrochemical spreads in Q2 2026, normalizing from Q3 as supply stabilizes.
Complementary Law No. 228 increased the REIQ benefit for the chemical industry, providing significant tax credits through December 2026.
Projections assume the Middle East conflict ends in May; prolonged conflict could further impact spreads and demand.
The sector faces continued macroeconomic uncertainties, commodity price volatility, and evolving regulatory/tax environments.
Latest events from Braskem
- EBITDA dropped 49% in 2025, leverage rose, and restructuring is underway amid industry headwinds.BRKM5
Q4 20259 Apr 2026 - EBITDA rose 39–46% to $320M, with strong liquidity, but net loss deepened on currency impacts.BRKM5
Q2 20242 Feb 2026 - EBITDA surged 35% to $432M, led by Brazil and Green PE, but Q4 faces seasonal and market risks.BRKM5
Q3 202415 Jan 2026 - 2030 targets: 1M tons each of bio-based and recycled products, with ambitious decarbonization goals.BRKM5
Investor Day 202412 Jan 2026 - EBITDA up 46% to US$1.1B; net loss US$2.2B; strong liquidity; focus on green growth.BRKM5
Q4 202426 Dec 2025 - Recurring EBITDA plunged 67% to US$74 million, with high leverage and ongoing transformation efforts.BRKM5
Q2 202523 Nov 2025 - EBITDA more than doubled on higher spreads and utilization, but Alagoas risks persist.BRKM5
Q1 202520 Nov 2025 - EBITDA doubled sequentially, but net loss and high leverage persisted amid industry headwinds.BRKM5
Q3 202513 Nov 2025